The early invasive strategy revisited: FRISC II at 5 years

Research output: Contribution to journal › Comment/debate

Access to Document

@article{161162f6584140ab9f6799284f1284d5,

title = "The early invasive strategy revisited: FRISC II at 5 years",

author = "Bach, \{Richard G.\}",

note = "Funding Information: I have received grant support from Eli Lilly and Merck, and lecture fees from Bristol-Myers Squibb and Sanofi-Aventis",

year = "2006",

month = sep,

day = "16",

doi = "10.1016/S0140-6736(06)69393-8",

language = "English",

volume = "368",

pages = "966--969",

journal = "Lancet",

issn = "0140-6736",

number = "9540",

}

TY - JOUR

T1 - The early invasive strategy revisited

T2 - FRISC II at 5 years

AU - Bach, Richard G.

N1 - Funding Information: I have received grant support from Eli Lilly and Merck, and lecture fees from Bristol-Myers Squibb and Sanofi-Aventis

PY - 2006/9/16

Y1 - 2006/9/16

UR - https://www.scopus.com/pages/publications/33748474943

U2 - 10.1016/S0140-6736(06)69393-8

DO - 10.1016/S0140-6736(06)69393-8

M3 - Comment/debate

C2 - 16980093

AN - SCOPUS:33748474943

SN - 0140-6736

VL - 368

SP - 966

EP - 969

JO - Lancet

JF - Lancet

IS - 9540

ER -